Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

Clinical trial NCT05323734 · COMPLETED

Trial details

NCT number: NCT05323734
Sponsor: Marinus Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tuberous Sclerosis Complex

Start date: 2022-04-01
Primary completion: 2024-09-09
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.